Daniel Kappel

Daniel Kappel is a seasoned professional in clinical research and compliance with extensive experience in proposal strategy and business development within the healthcare sector. Currently serving as Proposal Strategy Manager at Illingworth Research Group since November 2019, Kappel is responsible for developing customized trial strategies and enhancing the organization's value proposition. Previous roles include compliance management at DaVita Kidney Care and Kaiser Permanente, where responsibilities encompassed ensuring adherence to regulatory standards and fostering research integrity. Daniel Kappel has also contributed to education and quality assurance at the University of Colorado Anschutz Medical Campus and provided management consulting for clinical research at Huron Consulting Group. Kappel holds a Master of Arts in Bioethics from the Medical College of Wisconsin and a Bachelor of Arts in Sociology and History of Science, Medicine, and Technology from the University of Wisconsin-Madison.